COVID-19 drug candidate

A researcher at Celltrion Inc. shows CT-P59, a candidate COVID-19 antibody treatment being developed by the pharmaceutical company, to the media at its plant in Incheon, west of Seoul, on Dec. 22.
- Read more about COVID-19 drug candidate
- Log in to post comments